A Study to Assess the Efficacy and Safety of Budesonide/Albuterol Metered-dose Inhaler (BDA MDI/PT027) in Adults and Children 4 Years of Age or Older With Asthma
Targeted Disease(s):
Asthma
Purpose of Study:
A study to assess the efficacy and safety of budesonide/albuterol meter-dosed inhaler (BDA MDI/PT027) in adults and children 4 years of age or older with asthma (MANDALA)
Study Dates:
December 27, 2018 - December 1, 2021
Study Location:
Nationwide
Your tax-deductible donation funds lung disease and lung cancer research, new treatments, lung health education, and more.
Make a Donation